CAS 70209-81-3

Ivermectin B1b

Description:

Ivermectin B1b is a macrocyclic lactone compound that is part of the avermectin family, primarily known for its antiparasitic properties. It is derived from the fermentation of the soil bacterium Streptomyces avermitilis. This compound exhibits a broad spectrum of activity against various parasites, including nematodes and arthropods, making it widely used in veterinary medicine and some human applications. Ivermectin B1b functions by binding to glutamate-gated chloride channels, leading to increased permeability of the cell membrane to chloride ions, ultimately causing paralysis and death of the parasites. The substance is typically administered orally or topically, depending on the target organism. Ivermectin B1b is characterized by its relatively low toxicity in mammals, which contributes to its safety profile when used appropriately. However, it is essential to adhere to recommended dosages, as overdosing can lead to adverse effects. Its efficacy and safety have made it a critical component in the control of parasitic infections in both livestock and humans.

Formula: C₄₇H₇₂O₁₄

InChI: InChI=1S/C47H72O14/c1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h11-14,18,24-25,27,29-30,32-44,48-49,51H,15-17,19-23H2,1-10H3/b12-11+,26-14+,31-13+/t25-,27-,29-,30-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42-,43-,44+,46+,47+/m0/s1

InChI key: InChIKey=VARHUCVRRNANBD-PVVXTEPVSA-N

SMILES: [C@H](C)(C)[C@H]1O[C@@]2(C[C@@]3(C[C@](O2)(C/C=C(\C)/[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)/C=C/C=C\6/[C@@]7(O)[C@](C(=O)O3)(C=C(C)[C@@H](O)[C@]7(OC6)[H])[H])[H])[H])CC[C@@H]1C

Synonyms:

• (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-(1-methylethyl)-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-ribo-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside
• (2aE,4E,8E)-(5'S,6S,6'R,7S,11R,13R,15S,17aR,20R,20aR,20bS)-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-Tetradecahydro-20,20b-dihydroxy-6'-isopropyl-5',6,8,19-tetramethyl-17-oxospiro(11,15-methano-2H,13H,17H-furo(4,3,2-pq)(2,6)benzodioxacyclooctadecin-13,2'-(2H)pyran)-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyran
• (2aE,4E,8E)-(5'S,6S,6'R,7S,11R,13R,15S,17aR,20R,20aR,20bS)-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-Tetradecahydro-20,20b-dihydroxy-6'-isopropyl-5',6,8,19-tetramethyl-17-oxospiro(11,15-methano-2H,13H,17H-furo(4,3,2-pq)(2,6)benzodioxacyclooctadecin-13,2'-(2H)pyran)-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
• 22,23-Dihydroavermectin B_1b
• 5-O-Demethyl-25-de(1-methylpropyl)-22,23-dihydro-25-(1-methylethyl)avermectin A_1a
• Avermectin A(sub 1a), 5-O-demethyl-25-de(1-methylpropyl)-22,23-dihydro-25-(1-methylethyl)-
• Avermectin A_1a, 5-O-demethyl-25-de(1-methylpropyl)-22,23-dihydro-25-(1-methylethyl)-
• Avermectin H2B1b
• Ivermectin B1b
• Ivermectin B_1b
• Ivermectin component B(sub 1b)
• Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2′-[2H]pyran], avermectin A_1a deriv.
• Unii-0W28Cyi3Tu
• Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2′-[2H]pyran], avermectin A1a deriv.
• 22,23-Dihydroavermectin B1b
• Avermectin A1a, 5-O-demethyl-25-de(1-methylpropyl)-22,23-dihydro-25-(1-methylethyl)-

Ivermectin B1b

CAS: 70209-81-3

Ivermectin B1b, minor antiparasitic, binds to nematode glutamate channels, causing lasting hyperpolarization and paralysis.

Formula: C₄₇H₇₂O₁₄

Color and Shape: Solid

Molecular weight: 861.079

Ref: TM-T37748

Ivermectine B1b

CAS: 70209-81-3

Color and Shape: Neat

Ref: 04-CA14488007

Ivermectin B1b

CAS: 70209-81-3

Formula: C₄₇H₇₂O₁₄

Molecular weight: 861.08

Ref: 4Z-I-077019

Ivermectin B1b

Controlled Product

CAS: 70209-81-3

Formula: C₄₇H₇₂O₁₄

Color and Shape: Off White

Molecular weight: 861.066

Ref: TR-I940825

22,23-Dihydroavermectin B1b (Ivermectin B1b)

CAS: 70209-81-3

Ivermectin is a drug that belongs to the anthelmintic class of drugs. It is active against roundworms, pinworms, and hookworms. Ivermectin has been shown to have an effect on autoimmune diseases such as multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis by inhibiting the inflammatory response. The drug has been shown to inhibit matrix metalloproteinases in vitro and in vivo. The matrix effect is seen when the drug binds to proteins in the blood plasma or tissue matrix, where it inhibits their activity. This inhibition prevents the degradation of collagen, which can lead to tissue damage or renal failure. Ivermectin also binds to striatal dopamine receptors and inhibits dry weight gain in animals infected with Ostertagia ostertagi. Ivermectin is given orally in a single dose of 200 micrograms/kg body weight for treatment of intestinal worms (roundworm,

Formula: C₄₇H₇₂O₁₄

Purity: Min. 95%

Molecular weight: 861.07 g/mol

Ref: 3D-FD177819

Ivermectin B1b

CAS: 70209-81-3

Formula: C₄₇H₇₂O₁₄

Molecular weight: 861.08

Ref: ST-EA-CP-I18018